Abstract:Elevated expression and activity of N-acetylglucosaminyltransferase V (Mgat5) in hepatocellular carcinoma (HCC) is a common early event involved in tumor invasion during hepatocarcinogenesis. A better understanding of the functional role and the molecular mechanism for Mgat5-targeted protein and downstream signaling pathway behind hepatoma invasion and metastasis is urgently needed. Here, we show that Mgat5 overexpression promoted anchorage-independent growth and inhibited anoikis in hepatoma cells. This effect was reversed by glycosyltransferase inactive mutant Mgat5 L188R transfection, alpha-mannosidase II inhibitor swainsonine treatment and N-acetyl glucosamine (GlcNAc) phosphotransferase (GPT) inhibitor tunicamycin administration. Mgat5 overexpression increased p21-activated kinase 1 (PAK1) expression and shRNA-mediated PAK1 knockdown and kinase inactivation with kinase dead mutant PAK1 K299R coexpression or allosteric inhibitor P21-activated kinase inhibitor III (IPA3) treatment reversed anoikis resistance in Mgat5-overexpressed hepatoma cells. Furthermore, Mgat5 overexpression upregulated beta-1-6-GlcNAc branched N-glycosylation and following phosphorylation of epidermal growth factor receptor (EGFR) in hepatoma cells. EGFR tyrosine kinase inhibitors AG1478 and Iressa treatment declined anchorage-independent growth and anoikis resistance, which could be rescued by constitutive active mutant PAK1 T423E coexpression in Mgat5-overexpressed hepatoma cells. Conversely, knockdown of Mgat5 reduced EGFR/PAK1-dependent anoikis resistance, which could be reversed by PAK1 T423E. These results identified Mgat5-mediated beta-1-6-GlcNAc branched N-glycosylation and following activation of EGFR as a potential novel upstream molecular event for PAK1-induced anoikis resistance in hepatoma cells, implicating that molecular targeted therapeutics against Mgat5/EGFR/PAK1 might open a new avenue for personalized medicine in advanced-stage HCC patients.

Knockdown of N‐acetylglucosaminyltransferase V Inhibits Breast Cancer Cell Growth with Activation of CD4+T Cells and Macrophages

Knockdown of Mgat5 Inhibits Breast Cancer Cell Growth with Activation of Cd4+ T Cells and Macrophages

Knockdown of Mgat5 Inhibits CD133+ Human Pulmonary Adenocarcinoma Cell Growth in Vitro and in Vivo.

Downregulation of the Gnt-V Gene Inhibits Metastasis and Invasion of Bgc823 Gastric Cancer Cells

N-glycosylation by Mgat5 imposes a targetable constraint on immune-mediated tumor clearance

N-acetylglucosaminyltransferase V confers hepatoma cells with resistance to anoikis through EGFR/PAK1 activation.

Expression Of N-Acetylglucosaminyltransferase V In Gastric Cancer Correlates With Metastasis And Prognosis

Clinical and prognostic implications of β1, 6-N-acetylglucosaminyltransferase V in patients with gastric cancer.

Expression and Function of Mgat5 in CD133+ Pulmonary Adenocarcinoma Cells

N-acetylglucosaminyltransferase V Mediates Cell Migration and Invasion of Mouse Mammary Tumor Cells 4TO7 Via RhoA and Rac1 Signaling Pathway.

Promoting Effect of N-AcetylglucosaminyltransferaseⅡon the Migration of Mouse Breast Cancer Cell

Ganoderic acid T, a Ganoderma triterpenoid, modulates the tumor microenvironment and enhances the chemotherapy and immunotherapy efficacy through downregulating galectin-1 levels

Effect of GnT-V Knockdown on the Proliferation, Migration and Invasion of the SMMC7721/R Human Hepatocellular Carcinoma Drug-Resistant Cell Line.

N -acetylglucosaminyltransferase IVa regulates metastatic potential of mouse hepatocarcinoma cells through glycosylation of CD147

Knockdown of Microsomal Glutathione S-transferase 1 Inhibits Lung Adenocarcinoma Cell Proliferation and Induces Apoptosis.

Activity of N-acetylglucosaminyltransferase Ⅴ in Breast Cancer Tissues and Its Clinical Significance

Inhibition of N-acetylglucosaminyltransferase V Enhances Sensitivity of Radiotherapy in Human Prostate Cancer

Decreased miR-124-3p promoted breast cancer proliferation and metastasis by targeting MGAT5.

ppGalNAc-T4-catalyzed O-Glycosylation of TGF-β type II receptor regulates breast cancer cells metastasis potential

<Emphasis Type="Italic">N</Emphasis>-Acetylglucosaminyl 1-Phosphate Transferase: An Excellent Target for Developing New Generation Breast Cancer Therapeutic

Ppgalnac-T4-catalyzed O-Glycosylation of TGF-β Type Ⅱ Receptor Regulates Breast Cancer Cells Metastasis Potential